Serum protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy

Contraception

Volumn 16, Issue 4, 1977, Pages 399-407

  Saleh, Fawzia M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSE; HEXOSAMINE; HEXOSE; MEDROXYPROGESTERONE; NORETHISTERONE; OROSOMUCOID; SIALIC ACID DERIVATIVE; CARBOHYDRATE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; PLASMA PROTEIN; SIALIC ACID;

ARTICLE; BIOLOGY; BLOOD; CARBOHYDRATE METABOLIC EFFECTS; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE METHODS; CONTROLLED STUDY; DRUG EFFECT; FAMILY PLANNING; FEMALE; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; HUMAN; INJECTABLES; MEDROXYPROGESTERONE ACETATE--ADMINISTRACTION AND DOSAGE; MEDROXYPROGESTERONE ACETATE--SIDE EFFECTS; METABOLIC EFFECTS; METABOLISM; NORETHINDRONE ENANTHATE--ADMINISTRACTION AND DOSAGE; NORETHINDRONE ENANTHATE--SIDE EFFECTS; NORETHINDRONE--ADMINISTRACTION AND DOSAGE; NORETHINDRONE--SIDE EFFECTS; PHYSIOLOGY; PLASMA PROTEIN BINDING CAPACITY; PROTEIN BINDING; RESEARCH METHODOLOGY; STUDIES; TIME; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; ORAL CONTRACEPTION; SEROMUCOID; SERUM; THEORETICAL STUDY;

BIOLOGY; CARBOHYDRATE METABOLIC EFFECTS; CLINICAL RESEARCH; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE METHODS; FAMILY PLANNING; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; INJECTABLES; MEDROXYPROGESTERONE ACETATE--ADMINISTRACTION AND DOSAGE; MEDROXYPROGESTERONE ACETATE--SIDE EFFECTS; METABOLIC EFFECTS; NORETHINDRONE ENANTHATE--ADMINISTRACTION AND DOSAGE; NORETHINDRONE ENANTHATE--SIDE EFFECTS; NORETHINDRONE--ADMINISTRACTION AND DOSAGE; NORETHINDRONE--SIDE EFFECTS; PHYSIOLOGY; PLASMA PROTEIN BINDING CAPACITY; RESEARCH METHODOLOGY; STUDIES;

FEMALE; FUCOSE; HEXOSAMINES; HEXOSES; HUMAN; MEDROXYPROGESTERONE; NORETHINDRONE; OROSOMUCOID; PROTEIN BINDING; SIALIC ACIDS; TIME FACTORS;

EID: 0017624567     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(77)90051-8     Document Type: Article

References (27)

1. Physiologic and morphologic alterations affected by the contraceptive use of depo-medroxy-progesterone acetate
2. Medroxyprogesterone acetate and carbohydrate metabolism: Measurement of glucose, insulin and growth hormone during 6 months time
3. The effects of medroxyprogesterone acetate on carbohydrate metabolism, measurements of glucose, insulin and growth hormone after twelve months of use
4. Depo-medroxyprogesterone acetate as a contraceptive aaent: its effect on weight and blood pressure
5. Injectable medroxyprogesterone acetate contraception: Metabolic and endocrine effects
6. Effects of medroxy-progesterone acetate on carbohydrate metabolism
7. Effects of a long acting contraceptive drug, norethindrone enanthate, on serum zinc and copper in human volunteers
8. Studies on biosynthesis of glucosamine in the intact rat
9. 14C into liver and plasma proteins of the rat
10. 14C into protein-bound hexosamine and N-acetyl neuraminic acid in the normal rat
11. The serum polysaccharide level in malignancy and in other pathological conditions
12. Serum fucose levels during pregnancy and while taking oral contraceptives
13. Study of some blood glycoproteins in fibroid uterus, malignancy of the female genital tract and after the use of oral contraceptive pills
14. Serum protein-bound carbohydrate and seromucoid in pill users
15. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins
16. Estrogens and plasma oroso-mucoid
17. Estrogen dosage effects on serum proteins: A longitudinal study
18. Serum protein concentrations in pregnancy. II. Concentration in cord serum and amniotic fluid
19. Elevation of certain plasma proteins in man following estrogen administration: A dose-response relationship
20. Raised serum copper and ceruloplasmin levels in subjects taking oral contraceptives
21. Serum protein alterations produced in women by synthetic estrogens
22. Effect of estrogens on the haptoglobin level in the blood
23. The serum mucoproteins as an aid in the differentiation of neoplastic from primary parenchymatous liver disease
24. Liver damage from oral contraceptives
25. Hormones and the liver. The effects of estrogens, progestins and pregnancy on hepatic function
26. Liver function tests after the use of long-acting progestational contraceptives